Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Pulse Biosciences (PLSE).
Pulse Biosciences, Inc. has made significant board changes, electing Paul A. LaViolette as a director and appointing him to various leadership roles, including co-chairman and head of the new Strategic Advisory Committee. LaViolette, a seasoned healthcare executive with 40 years of experience, also received stock options as part of his non-employee director compensation. The company revised its compensation policy for non-employee directors, enhancing cash and equity compensation to align with their increased responsibilities and committee service.
For an in-depth examination of PLSE stock, go to TipRanks’ Stock Analysis page.